[Hospital and long-term prognosis of patients with non-ST-segment elevation myocardial infarction]

András Jánosi1, Dániel Várnai, Zsófia Adám

  • 1Fovárosi Onkormányzat Szent János Kórháza és Eszak-budai Egyesített Kórházak III, Belgyógyászat-Kardiológia, Budapest. janosiandrasdr@gmail.com

Orvosi Hetilap
|November 4, 2008
PubMed

Insights

This study on non-ST-segment elevation myocardial infarction found older age and specific echocardiographic factors predict mortality. Medication adherence remained high post-discharge.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • Non-ST-segment elevation myocardial infarction (NSTEMI) is a significant cause of cardiac mortality.
  • Understanding long-term prognosis and predictors of mortality in NSTEMI patients is crucial for effective management.
  • Comorbidities like diabetes, hypertension, and prior ischemic heart disease are common in NSTEMI populations.

Purpose of the Study:

  • To analyze the clinical data, hospital, and long-term prognosis of patients with NSTEMI.
  • To identify predictors of mortality, including demographic, clinical, and echocardiographic factors.
  • To evaluate medication adherence to guideline recommendations at hospital discharge and during follow-up.

Main Methods:

  • Retrospective analysis of clinical data from 139 consecutive NSTEMI patients.
  • A three-quarter-year follow-up using postal questionnaires, achieving 98% completion.
  • Assessment of echocardiographic parameters and hospital discharge medications.

Main Results:

  • The mean age was 78.6 years for females and 71.4 years for males, with high comorbidity rates.
  • Hospital mortality was 15%, and 17% died during the follow-up period. Older age was associated with higher mortality.
  • Prognostically important echocardiographic parameters included ejection fraction, end-systolic diameter, wall motion abnormality, and mitral regurgitation severity.

Conclusions:

  • Older age and specific echocardiographic findings are significant predictors of mortality in NSTEMI patients.
  • Hospital discharge medication adherence in this cohort was notably high and sustained post-discharge.
  • These findings highlight the importance of comprehensive assessment and guideline-based care in NSTEMI management.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...